{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:39:50Z","timestamp":1762004390231},"reference-count":16,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Cerebral nocardiosis is a severe infection that carries the highest mortality rate among all bacterial cerebral abscesses. We report on a case in an immunocompromised patient which was successfully treated with unexpectedly low doses of linezolid. Therapeutic drug monitoring was very helpful in highlighting issues of poor compliance and of drug-drug interactions.<\/jats:p>","DOI":"10.1128\/aac.00135-12","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T05:56:18Z","timestamp":1330408578000},"page":"3438-3440","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["Successful Long-Term Treatment of Cerebral Nocardiosis with Unexpectedly Low Doses of Linezolid in an Immunocompromised Patient Receiving Complex Polytherapy"],"prefix":"10.1128","volume":"56","author":[{"given":"Federico","family":"Pea","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Department of Experimental and Clinical Medical Sciences, Medical School, University of Udine, Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiorgio","family":"Cojutti","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Department of Experimental and Clinical Medical Sciences, Medical School, University of Udine, Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Pagotto","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cristini","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Internal Medicine, Geriatrics and Nephrologic Diseases, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Furlanut","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Department of Experimental and Clinical Medical Sciences, Medical School, University of Udine, Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Internal Medicine, Geriatrics and Nephrologic Diseases, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-009-9193-9"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1472-8206.2006.00408.x","article-title":"Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein","volume":"20","author":"Bachmakov I","year":"2006","unstructured":"BachmakovI WernerU EndressB AugeD FrommMF. 2006. Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein. Fundam. Clin. Pharmacol. 20:273\u2013282.","journal-title":"Fundam. Clin. Pharmacol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.19.2.259-282.2006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1295-1297.2001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/00365549509018968","article-title":"Human nocardiosis in northern Italy from 1982 to 1992. Northern Italy Collaborative Group on Nocardiosis","volume":"27","author":"Farina C","year":"1995","unstructured":"FarinaC BoironP GoglioA ProvostF. 1995. Human nocardiosis in northern Italy from 1982 to 1992. Northern Italy Collaborative Group on Nocardiosis. Scand. J. Infect. Dis. 27:23\u201327.","journal-title":"Scand. J. Infect. Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1345\/aph.1K196","article-title":"Linezolid for the treatment of Nocardia spp. infections","volume":"41","author":"Jodlowski TZ","year":"2007","unstructured":"JodlowskiTZ MelnychukI ConryJ. 2007. Linezolid for the treatment of Nocardia spp. infections. Ann. Pharmacother. 41:1694\u20131699.","journal-title":"Ann. Pharmacother."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0928-0987(00)00215-3","article-title":"Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport","volume":"12","author":"Katoh M","year":"2001","unstructured":"KatohM NakajimaM YamazakiH YokoiT. 2001. Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport. Eur. J. Pharm. Sci. 12:505\u2013513.","journal-title":"Eur. J. Pharm. Sci."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1023\/A:1007568811691","article-title":"Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4","volume":"17","author":"Katoh M","year":"2000","unstructured":"KatohM NakajimaM YamazakiH YokoiT. 2000. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4. Pharm. Res. 17:1189\u20131197.","journal-title":"Pharm. Res."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/345907"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00051-06"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1345\/aph.1H307","article-title":"Linezolid for the treatment of patients with central nervous system infection","volume":"41","author":"Ntziora F","year":"2007","unstructured":"NtzioraF FalagasME. 2007. Linezolid for the treatment of patients with central nervous system infection. Ann. Pharmacother. 41:296\u2013308.","journal-title":"Ann. Pharmacother."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00210-001-0489-7","article-title":"Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein","volume":"364","author":"Pauli-Magnus C","year":"2001","unstructured":"Pauli-MagnusC RekersbrinkS KlotzU FrommMF. 2001. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. Naunyn Schmiedebergs Arch. Pharmacol. 364:551\u2013557.","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00177-10"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/499533"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-010-0080-6"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0163-4453(09)60009-8","article-title":"Linezolid: a review of safety and tolerability","volume":"59","author":"Vinh DC","year":"2009","unstructured":"VinhDC RubinsteinE. 2009. Linezolid: a review of safety and tolerability. J. Infect. 59(Suppl. 1):S59\u2013S74.","journal-title":"J. Infect."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00135-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00135-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:05:56Z","timestamp":1645481156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00135-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1128\/AAC.00135-12"],"URL":"https:\/\/doi.org\/10.1128\/aac.00135-12","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"2012-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-02-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-05-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}